BRIEF-Actinogen Provides Pivotal Alzheimer’S Trial Enrolment Update

Reuters
30 Apr
BRIEF-Actinogen Provides Pivotal Alzheimer’S Trial Enrolment Update

April 30 (Reuters) - Actinogen Medical Ltd ACW.AX:

  • ACTINOGEN PROVIDES PIVOTAL ALZHEIMER’S TRIAL ENROLMENT UPDATE AND OTHER BUSINESS NEWS

  • ACTINOGEN MEDICAL LTD - ALZHEIMER'S PHASE 2B/3 TRIAL ENROLLS 60 PARTICIPANTS, EXPECTS 100 BY QUARTER-END

  • ACTINOGEN MEDICAL LTD - FINAL RESULTS FOR 220 PARTICIPANTS EXPECTED IN Q4 2026

Source text: ID:nGNXbBbW0y

Further company coverage: ACW.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10